Results 1 to 10 of about 9,067 (180)
Candida auris: a Review of the Literature [PDF]
Clinical Microbiology Reviews, 2018 SUMMARY The emerging pathogen Candida auris has been associated with nosocomial outbreaks on five continents. Genetic analysis indicates the simultaneous emergence of separate clades of this organism in different geographical locations.
Silke Schelenz +2 more
exaly +3 more sources
Development of a Loop-Mediated Isothermal Amplification (LAMP) for the screening of Candida auris. [PDF]
PLoS ONEBackgroundCandida auris is an emerging multidrug-resistant yeast associated with invasive infections, healthcare-associated outbreaks, and high mortality, and is often misidentified by conventional diagnostic methods.
Woong Sik Jang +4 more
doaj +2 more sources
NursingAbstract: Candida auris (C. auris) is a human pathogen that can colonize the skin and various body sites without signs or symptoms or cause serious invasive infections with high mortality. The number of cases involving drug-resistant C. auris infections have increased in the US in recent years.
Jenks JD, Tobin EH, Zahra F.
europepmc +5 more sources
Candida auris: What Have We Learned About Its Mechanisms of Pathogenicity?
Frontiers in Microbiology, 2018 Candida auris has emerged globally as a multidrug-resistant (MDR) medical care-associated fungal pathogen. Recent reports have demonstrated that C. auris usually expresses fewer virulence factors than does Candida albicans.
+2 more
exaly +3 more sources
Biocide Response of Candida auris. [PDF]
MycosesABSTRACT Candida auris is an emerging multidrug‐resistant yeast demonstrating remarkable persistence in healthcare environments, contributing to nosocomial transmission and outbreak persistence.
Erganis S +3 more
europepmc +2 more sources
Accelerated Increase in Candida auris Bloodstream Infections during COVID-19 Pandemic, South Africa [PDF]
Emerging Infectious DiseasesThe COVID-19 pandemic coincided with rising secondary bloodstream infections (BSIs) from multidrug-resistant organisms, including Candida auris. To assess candidemia trends, we conducted a retrospective analysis of blood culture isolates from public and
Husna Ismail +8 more
doaj +2 more sources
Candida auris: Epidemiology and Antifungal Strategy
Annual Review of MedicineCandida auris is a recently emerged fungal pathogen that causes severe infections in healthcare settings around the globe. A feature that distinguishes C. auris from other fungal pathogens is its high capacity to colonize skin, leading to widespread outbreaks in healthcare
Jeniel Nett
exaly +3 more sources
The Second Case of Candida auris Candidemia from Turkey: An Impending Threat to the Global Health
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2021 Candida auris is a rapidly emerging fungus, which is considered globally a cause of concern for public health. This report describes Turkey’s second case of Candida auris fungemia from a tertiary care hospital in İstanbul.
Leyla TEKE +2 more
doaj +1 more source
BMC Infectious Diseases, 2021 Background Candida auris infections are an emerging global threat with poor clinical outcome, high mortality rate, high transmission rate and outbreak potential.
Dipu Thareparambil Sathyapalan +13 more
doaj +1 more source
Candida auris in the Age of Resistance [PDF]
Cureus, 2020 Candida auris (C. auris) is an opportunistic ascomycetous budding yeast that has been emerging as an invasive, multidrug-resistant pathogen over the past 10 years since its discovery. This fungi is the first to be labeled as a public health threat according to the Centers for Disease Control (CDC) and has since become a major problem in the United ...
Oh, Michael +2 more
openaire +2 more sources